Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05130281 · ClinicalTrials.gov registry record · NA
Mobile Cognitive Behavior Therapy Targeting Anxiety Disorders
A NA study of Anxiety Disorders and Symptoms, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT05130281: Completed NA study of Anxiety Disorders and Symptoms, sponsored by Weill Medical College of Cornell University.
NCT05130281 is a NA study of Anxiety Disorders and Symptoms that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 59 participants, below the 130-participant average among 9 other Anxiety Disorders and Symptoms trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05130281, a NA study of Anxiety Disorders and Symptoms, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to examine different ways of motivating people to make use of Maya, a mobile cognitive behavior therapy (CBT) program for adolescents and young adults experiencing anxiety symptoms, and to assess whether social supports are as efficacious, or more efficacious, than other non-monetary incentives. Subjects will use the Maya app for at least 20 minutes per day, 2 days per week, for 6 weeks. Assessments will include a weekly check in with a member of the research team, questionnaires, and an optional magnetic resonance imaging (MRI) recording.
Primary Outcome
Change in anxiety between the three incentive conditions will be measured using the Hamilton Rating Scale for Anxiety (HAM-A), a 14-item questionnaire measure of the severity of anxiety symptoms. The items measure both psychic anxiety and somatic anxiety, where higher scores, defined by a score range of 18-56, indicate a greater presence of symptoms and lower scores, defined by a score range of 0-17, indicate mild to no anxiety symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Social Support
- BEHAVIORAL Maya mobile app
- BEHAVIORAL Gain Framed
- BEHAVIORAL Loss Framed
Study Locations (1)
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2021-06-18 |
| Est. Completion | 2022-12-08 |
| Phase | NA |
What the finished NCT05130281 record still lists
NCT05130281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 130-participant average among 9 other Anxiety Disorders and Symptoms trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Anxiety Disorders and Symptoms appearing as the primary indexed condition, and to 4 interventions - of which Social Support is the first listed.
NCT05130281 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05130281 about?
NCT05130281 is a clinical study titled "Mobile Cognitive Behavior Therapy Targeting Anxiety Disorders". This study aims to examine different ways of motivating people to make use of Maya, a mobile cognitive behavior therapy (CBT) program for adolescents and young adults experiencing anxiety symptoms, and to assess whether social supports are as efficacious, or more efficacious, than other non-monetary...
What is the current status of trial NCT05130281?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2021-06-18. Estimated completion is 2022-12-08.
What conditions does trial NCT05130281 study?
This clinical trial studies the following conditions: Anxiety Disorders and Symptoms.
What interventions are being tested in trial NCT05130281?
The interventions under investigation include: Social Support (BEHAVIORAL), Maya mobile app (BEHAVIORAL), Gain Framed (BEHAVIORAL), Loss Framed (BEHAVIORAL).
Who is sponsoring clinical trial NCT05130281?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05130281 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders and Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05130281's enrollment target sits among peer trials
59 8th of 9 higher than 2 of 9 other Anxiety Disorders and Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders and Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalizing Treatment Delivery
RECRUITING · NA
-
Family Spirit Strengths
RECRUITING · NA
-
Mobile CBT for Middle Aged and Older Adults
RECRUITING · NA
-
Personalized Mobile Cognitive Behavioral Therapy Application
RECRUITING · NA
-
Evaluating a Virtual Mentoring Program Plus Mental Health Videos for Teens
ACTIVE NOT RECRUITING · NA
-
Adapting Project UPLIFT for Blacks in Georgia
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI